AlJadaan: Leaders of Gulf Countries are Keen for Gulf Cooperation Council to Reach Highest Levels of Economic Integration    1.5m clients benefit from digital conveyance of title deeds service    Umrah companies obligated to issue permits for its pilgrims    Saudi Arabia retains its seat in ITU Council by international consensus    RCU launches Safar art exhibition at AlUla airport    Iran's supreme leader blames unrest on US and Israel    Speaker of Shura Council Heads Kingdom's Delegation to 8th G20 Parliamentary Speakers' Summit in Jakarta    Saudi Stock Exchange Main Index Ends Trading Higher at 11,607.96 Points    Saudi Minister of Commerce Heads Delegation to Morocco, Discusses Enhancing Commercial, Investment Relations    Qatar Stock Exchange Ends Trading Higher    Saudi Arabia to host World Petroleum Congress in 2026    Jazan International Forum moots Saudi Coffee Day, Annual Coffee Award    Sultan Humanitarian City wins platinum award at 2022 Patient Safety Congress in Dubai    King, Crown Prince congratulate German president on Unity Day    Brazil election: Lula and Bolsonaro to face run-off    UK chancellor U-turns on plans to scrap tax rate    Record avian flu outbreak sees 48 million birds culled in UK and EU    Fans 'died in the arms' of players in Indonesia stadium crush    Fans of Sydney United 58 condemned for Nazi salutes during Australia Cup final    Tadawul All Share Index Decreases by 0.79%, Equity Market Capitalization Reaches SAR 10,832.85 Billion at End of 1st Nine Months 2022    Asian Shares Mostly Lower    Weather Forecast for Monday    KSrelief Concludes the 11th, 12th Volunteer Program in Zaatari Camp for Syrian Refugees in Jordan    flynas Launches the "Future Engineers Program" for Aircraft Engineering and Maintenance with 300 Saudi Engineers in Its First Batch    Al-Manea: Selling gold in installments is not permissible    MAWANI, Tabadul Sign MoU to Develop New Saudi Ports Management Systems    174 dead in Indonesian football stadium crush    At Least 127 People Killed, 180 Injured at Football Match in Indonesia    15 cups of Saudi coffee in a day are enough!    Riyadh hosts first Saudi Games on Oct. 27    19 women, 2 men qualify as Kingdom's first yogasana referees    Movies return to Kashmir with Hrithik Roshan-starrer    Body of famed US climber found on Mt Manaslu in Himalayas    Yoga introduced to Saudi universities    Islamic Minister Al-Sheikh: Juristic judgment catalyst to salvage Islamic Ummah    Culinary Arts Commission Registers 13 Foods on Slow Food List of Endangered Food    72% of Children Globally have been Victims of Cyber Threats    Saudi National Football Team Continues Preparations for Friendly Match against Ecuador    Saudi Futsal Team Beats San Marino, Wins Silver in Croatian International Championship    During 2nd Global AI Summit.. AI-powered Early Breast Cancer Detection Program Launched    Triple talaq: India Muslim women in limbo after instant divorce ruling    Film Commission Reviews Film Industry Prospects in Saudi Arabia at Venice International Film Festival    Saudi national volleyball team loses to Kyrgyzstan in Asian Challenge Cup final    Saudi national volleyball team beats Uzbekistan, qualifies for the final of the Asian Challenge Cup    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



India approves AstraZeneca and local COVID-19 vaccines
Published in The Saudi Gazette on 03 - 01 - 2021

India's drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech and a state-run institute, Reuters reported.
The decisions mark the first vaccine approvals for the world's second-most populous country, which after the United States, has recorded the most infections of the coronavirus disease.
It is now expected to start a massive immunization program within about a week, a government official said, and hopes to inoculate 300 million of its 1.35 billion people free of charge in the first six to eight months of this year.
The drugs regulatory authority gave the green light to the jabs developed by AstraZeneca with Oxford University and by local firm Bharat Biotech. Prime Minister Narendra Modi called it "a decisive turning point".
On Saturday, India held nationwide drills to prepare more than 90,000 health care workers to administer vaccines across the country, which has a population of 1.3 billion people.
The Drugs Controller General of India said both manufacturers had submitted data showing their vaccines were safe to use.
The Oxford/AstraZeneca vaccine is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer. It says it is producing more than 50 million doses a month.
Adar Poonawalla, the company's CEO, told the BBC in November that he aimed to ramp up production to 100 million doses a month after receiving regulatory approval.
The jab, which is known as Covishield in India, is administered in two doses given between four and 12 weeks apart.
It can be safely stored at temperatures of 2C to 8C, about the same as a domestic fridge, and can be delivered in existing health care settings such as doctors' surgeries.
This makes it easier to distribute than some of the other vaccines. The jab developed by Pfizer/BioNTech - which is currently being administered in several countries — must be stored at -70C and can only be moved a limited number of times — a particular challenge in India, where summer temperatures can reach 50C.
The local vaccine, however, was approved despite the absence of data on how efficient it can be. It has yet to go through large-scale trials.
The Drugs Controller General, V.G. Somani, said Bharat Biotech's Covaxin was "safe and provides a robust immune response".
Somani said it had been approved "in public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains".
Pfizer, whose vaccine has already been approved for use in jurisdictions including the UK, the US and the EU, is also seeking emergency authorization in India. In all, some 30 vaccine candidates are being developed in India.. — Agencies


Clic here to read the story from its source.